No Evidence for Interference of H&E Staining in DNA Testing
Teppei Morikawa(Dana-Farber Cancer Institute), Shuji Ogino(Broad Institute), Aya Kuchiba(Kanagawa University of Human Services), Mohan Brahmandam(Dana-Farber Cancer Institute), Charles S. Fuchs(University of Southern California), Yu Imamura(Japanese Foundation For Cancer Research), Janina A. Longtine(Boston Children's Hospital), Xiaoyun Liao(Bristol-Myers Squibb (Germany)), Zhi Rong Qian(Dana-Farber Cancer Institute), Noriko Tanaka(National Center for Global Health and Medicine), Kaori Shima(Harvard University), Mai Yamauchi(Harvard University), Neal I. Lindeman(Cornell University)
Cited by 37
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k
Genomic analysis identifies association of <i>Fusobacterium</i> with colorectal carcinoma
|Genome Research|2011|2k